{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:33:49Z","timestamp":1787063629247,"version":"build-2736575974"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T00:00:00Z","timestamp":1601424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T00:00:00Z","timestamp":1601424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["Senior Research Fellowship"],"award-info":[{"award-number":["Senior Research Fellowship"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s11010-020-03925-1","type":"journal-article","created":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T18:37:36Z","timestamp":1601491056000},"page":"483-491","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Reactivation of fatty acid oxidation by medium chain fatty acid prevents myocyte hypertrophy in H9c2 cell line"],"prefix":"10.1007","volume":"476","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9976-0939","authenticated-orcid":false,"given":"Saifudeen","family":"Ismael","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Renuka","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,30]]},"reference":[{"key":"3925_CR1","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1161\/hc0102.101365","volume":"105","author":"G Esposito","year":"2002","unstructured":"Esposito G, Rapacciuolo A, Prasad SVN et al (2002) Genetic alterations that inhibit in vivo pressure-overload hypertrophy prevent cardiac dysfunction despite increased wall stress. Circulation 105:85\u201392. https:\/\/doi.org\/10.1161\/hc0102.101365","journal-title":"Circulation"},{"key":"3925_CR2","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1161\/01.CIR.0000120390.68287.BB","volume":"109","author":"N Frey","year":"2004","unstructured":"Frey N, Katus HA, Olson EN, Hill JA (2004) Hypertrophy of the heart: a new therapeutic target? Circulation 109:1580\u20131589. https:\/\/doi.org\/10.1161\/01.CIR.0000120390.68287.BB","journal-title":"Circulation"},{"key":"3925_CR3","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1056\/NEJM200001203420301","volume":"342","author":"S Yusuf","year":"2000","unstructured":"Yusuf S, Sleight P, Pogue J et al (2000) Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 342:145\u2013153. https:\/\/doi.org\/10.1056\/NEJM200001203420301","journal-title":"N Engl J Med"},{"key":"3925_CR4","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/cvr\/cvn301","volume":"81","author":"JS Ingwall","year":"2009","unstructured":"Ingwall JS (2009) Energy metabolism in heart failure and remodelling. Cardiovasc Res 81:412\u2013419. https:\/\/doi.org\/10.1093\/cvr\/cvn301","journal-title":"Cardiovasc Res"},{"key":"3925_CR5","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1161\/CIRCRESAHA.112.268128","volume":"111","author":"SC Kolwicz","year":"2012","unstructured":"Kolwicz SC, Olson DP, Marney LC et al (2012) Cardiac-specific deletion of acetyl CoA carboxylase 2 prevents metabolic remodeling during pressure-overload hypertrophy. Circ Res 111:728\u2013738. https:\/\/doi.org\/10.1161\/CIRCRESAHA.112.268128","journal-title":"Circ Res"},{"key":"3925_CR6","doi-asserted-by":"publisher","first-page":"H1585","DOI":"10.1152\/ajpheart.00599.2009","volume":"297","author":"DJ Chess","year":"2009","unstructured":"Chess DJ, Khairallah RJ, O\u2019Shea KM et al (2009) A high-fat diet increases adiposity but maintains mitochondrial oxidative enzymes without affecting development of heart failure with pressure overload. Am J Physiol Heart Circ Physiol 297:H1585\u20131593. https:\/\/doi.org\/10.1152\/ajpheart.00599.2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"3925_CR7","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1111\/j.1440-1681.2005.04272.x","volume":"32","author":"IC Okere","year":"2005","unstructured":"Okere IC, Chess DJ, McElfresh TA et al (2005) High-fat diet prevents cardiac hypertrophy and improves contractile function in the hypertensive dahl salt-sensitive rat. Clin Exp Pharmacol Physiol 32:825\u2013831. https:\/\/doi.org\/10.1111\/j.1440-1681.2005.04272.x","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"3925_CR8","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.cardfail.2007.11.003","volume":"14","author":"MK Duda","year":"2008","unstructured":"Duda MK, O\u2019Shea KM, Lei B et al (2008) Low-carbohydrate\/high-fat diet attenuates pressure overload-induced ventricular remodeling and dysfunction. J Card Fail 14:327\u2013335. https:\/\/doi.org\/10.1016\/j.cardfail.2007.11.003","journal-title":"J Card Fail"},{"key":"3925_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-015-2435-x","author":"S Ismael","year":"2015","unstructured":"Ismael S, Purushothaman S, Harikrishnan VS, Nair RR (2015) Ligand specific variation in cardiac response to stimulation of peroxisome proliferator-activated receptor-alpha in spontaneously hypertensive rat. Mol Cell Biochem. https:\/\/doi.org\/10.1007\/s11010-015-2435-x","journal-title":"Mol Cell Biochem"},{"key":"3925_CR10","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.cardfail.2016.08.001","volume":"23","author":"I Saifudeen","year":"2017","unstructured":"Saifudeen I, Subhadra L, Konnottil R, Nair RR (2017) Metabolic modulation by medium-chain triglycerides reduces oxidative stress and ameliorates CD36-mediated cardiac remodeling in spontaneously hypertensive rat in the initial and established stages of hypertrophy. J Card Fail 23:240\u2013251. https:\/\/doi.org\/10.1016\/j.cardfail.2016.08.001","journal-title":"J Card Fail"},{"key":"3925_CR11","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S0092-8674(00)81573-1","volume":"93","author":"JD Molkentin","year":"1998","unstructured":"Molkentin JD, Lu J-R, Antos CL et al (1998) A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93:215\u2013228","journal-title":"Cell"},{"key":"3925_CR12","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.devcel.2009.01.021","volume":"16","author":"JS Gutkind","year":"2009","unstructured":"Gutkind JS, Offermanns S (2009) A new Gq-initiated MAPK signaling pathway in the heart. Dev Cell 16:163\u2013164. https:\/\/doi.org\/10.1016\/j.devcel.2009.01.021","journal-title":"Dev Cell"},{"key":"3925_CR13","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/S1050-1738(99)00004-3","volume":"9","author":"GW Dorn","year":"1999","unstructured":"Dorn GW, Brown JH (1999) Gq signaling in cardiac adaptation and maladaptation. Trends Cardiovasc Med 9:26\u201334. https:\/\/doi.org\/10.1016\/S1050-1738(99)00004-3","journal-title":"Trends Cardiovasc Med"},{"key":"3925_CR14","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1124\/mol.113.086322","volume":"84","author":"W Zhu","year":"2013","unstructured":"Zhu W, Tilley DG, Myers VD et al (2013) Arginine vasopressin enhances cell survival via a g protein-coupled receptor kinase 2\/\u03b2-arrestin1\/extracellular-regulated kinase 1\/2\u2013dependent pathway in H9c2 cells. Mol Pharmacol 84:227\u2013235. https:\/\/doi.org\/10.1124\/mol.113.086322","journal-title":"Mol Pharmacol"},{"key":"3925_CR15","doi-asserted-by":"publisher","first-page":"8121","DOI":"10.1073\/pnas.94.15.8121","volume":"94","author":"DD D\u2019Angelo","year":"1997","unstructured":"D\u2019Angelo DD, Sakata Y, Lorenz JN et al (1997) Transgenic Galphaq overexpression induces cardiac contractile failure in mice. Proc Natl Acad Sci USA 94:8121\u20138126. https:\/\/doi.org\/10.1073\/pnas.94.15.8121","journal-title":"Proc Natl Acad Sci USA"},{"key":"3925_CR16","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1038\/nm1101-1236","volume":"7","author":"N Wettschureck","year":"2001","unstructured":"Wettschureck N, R\u00fctten H, Zywietz A et al (2001) Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of Galphaq\/Galpha11 in cardiomyocytes. Nat Med 7:1236\u20131240. https:\/\/doi.org\/10.1038\/nm1101-1236","journal-title":"Nat Med"},{"key":"3925_CR17","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1006\/jmcc.1997.0523","volume":"29","author":"MA Hefti","year":"1997","unstructured":"Hefti MA, Harder BA, Eppenberger HM, Schaub MC (1997) Signaling pathways in cardiac myocyte hypertrophy. J Mol Cell Cardiol 29:2873\u20132892. https:\/\/doi.org\/10.1006\/jmcc.1997.0523","journal-title":"J Mol Cell Cardiol"},{"key":"3925_CR18","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1006\/jmcc.2001.1427","volume":"33","author":"Y Takeishi","year":"2001","unstructured":"Takeishi Y, Huang Q, Abe J et al (2001) Src and multiple MAP kinase activation in cardiac hypertrophy and congestive heart failure under chronic pressure-overload: comparison with acute mechanical stretch. J Mol Cell Cardiol 33:1637\u20131648. https:\/\/doi.org\/10.1006\/jmcc.2001.1427","journal-title":"J Mol Cell Cardiol"},{"key":"3925_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1161\/01.res.76.1.1","volume":"76","author":"J Sadoshima","year":"1995","unstructured":"Sadoshima J, Qiu Z, Morgan JP, Izumo S (1995) Angiotensin II and other hypertrophic stimuli mediated by G protein-coupled receptors activate tyrosine kinase, mitogen-activated protein kinase, and 90-kD S6 kinase in cardiac myocytes. The critical role of Ca(2+)-dependent signaling. Circ Res 76:1\u201315. https:\/\/doi.org\/10.1161\/01.res.76.1.1","journal-title":"Circ Res"},{"key":"3925_CR20","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.1073\/pnas.031371998","volume":"98","author":"LJ De Windt","year":"2001","unstructured":"De Windt LJ, Lim HW, Bueno OF et al (2001) Targeted inhibition of calcineurin attenuates cardiac hypertrophy in vivo. Proc Natl Acad Sci USA 98:3322\u20133327. https:\/\/doi.org\/10.1073\/pnas.031371998","journal-title":"Proc Natl Acad Sci USA"},{"key":"3925_CR21","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1161\/01.CIR.103.5.670","volume":"103","author":"H Syed","year":"2001","unstructured":"Syed H, Gabriel C, Hae L et al (2001) Differential activation of signal transduction pathways in human hearts with hypertrophy versus advanced heart failure. Circulation 103:670\u2013677. https:\/\/doi.org\/10.1161\/01.CIR.103.5.670","journal-title":"Circulation"},{"key":"3925_CR22","doi-asserted-by":"publisher","first-page":"6819","DOI":"10.1073\/pnas.1132094100","volume":"100","author":"H Irie","year":"2003","unstructured":"Irie H, Krukenkamp IB, Brinkmann JFF et al (2003) Myocardial recovery from ischemia is impaired in CD36-null mice and restored by myocyte CD36 expression or medium-chain fatty acids. Proc Natl Acad Sci USA 100:6819\u20136824. https:\/\/doi.org\/10.1073\/pnas.1132094100","journal-title":"Proc Natl Acad Sci USA"},{"key":"3925_CR23","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1097\/FJC.0b013e3180544540","volume":"49","author":"F Brigadeau","year":"2007","unstructured":"Brigadeau F, Gel\u00e9 P, Wibaux M et al (2007) The PPARalpha activator fenofibrate slows down the progression of the left ventricular dysfunction in porcine tachycardia-induced cardiomyopathy. J Cardiovasc Pharmacol 49:408\u2013415. https:\/\/doi.org\/10.1097\/FJC.0b013e3180544540","journal-title":"J Cardiovasc Pharmacol"},{"key":"3925_CR24","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.yjmcc.2006.05.013","volume":"41","author":"S Ichihara","year":"2006","unstructured":"Ichihara S, Obata K, Yamada Y et al (2006) Attenuation of cardiac dysfunction by a PPAR-alpha agonist is associated with down-regulation of redox-regulated transcription factors. J Mol Cell Cardiol 41:318\u2013329. https:\/\/doi.org\/10.1016\/j.yjmcc.2006.05.013","journal-title":"J Mol Cell Cardiol"},{"issue":"50","key":"3925_CR25","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1161\/HYPERTENSIONAHA.107.092403","volume":"1979","author":"NK Lebrasseur","year":"2007","unstructured":"Lebrasseur NK, Duhaney T-AS, De Silva DS et al (2007) Effects of fenofibrate on cardiac remodeling in aldosterone-induced hypertension. Hypertens Dallas Tex 1979(50):489\u2013496. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.107.092403","journal-title":"Hypertens Dallas Tex"},{"key":"3925_CR26","doi-asserted-by":"publisher","first-page":"44390","DOI":"10.1074\/jbc.M103826200","volume":"276","author":"ME Young","year":"2001","unstructured":"Young ME, Laws FA, Goodwin GW, Taegtmeyer H (2001) Reactivation of peroxisome proliferator-activated receptor alpha is associated with contractile dysfunction in hypertrophied rat heart. J Biol Chem 276:44390\u201344395. https:\/\/doi.org\/10.1074\/jbc.M103826200","journal-title":"J Biol Chem"},{"key":"3925_CR27","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/FJC.0b013e31822368d7","volume":"58","author":"S Purushothaman","year":"2011","unstructured":"Purushothaman S, Sathik MM, Nair RR (2011) Reactivation of peroxisome proliferator-activated receptor alpha in spontaneously hypertensive rat: age-associated paradoxical effect on the heart. J Cardiovasc Pharmacol 58:254\u2013262. https:\/\/doi.org\/10.1097\/FJC.0b013e31822368d7","journal-title":"J Cardiovasc Pharmacol"},{"key":"3925_CR28","doi-asserted-by":"publisher","first-page":"H1899","DOI":"10.1152\/ajpheart.01014.2005","volume":"290","author":"EE Morgan","year":"2006","unstructured":"Morgan EE, Rennison JH, Young ME et al (2006) Effects of chronic activation of peroxisome proliferator-activated receptor-alpha or high-fat feeding in a rat infarct model of heart failure. Am J Physiol Heart Circ Physiol 290:H1899\u20131904. https:\/\/doi.org\/10.1152\/ajpheart.01014.2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"3925_CR29","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.cardfail.2007.09.004","volume":"14","author":"DJ Chess","year":"2008","unstructured":"Chess DJ, Lei B, Hoit BD et al (2008) Effects of a high saturated fat diet on cardiac hypertrophy and dysfunction in response to pressure overload. J Card Fail 14:82\u201388. https:\/\/doi.org\/10.1016\/j.cardfail.2007.09.004","journal-title":"J Card Fail"},{"key":"3925_CR30","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1161\/01.HYP.0000248430.26229.0f","volume":"48","author":"IC Okere","year":"1979","unstructured":"Okere IC, Young ME, McElfresh TA et al (1979) (2006) Low carbohydrate\/high-fat diet attenuates cardiac hypertrophy, remodeling, and altered gene expression in hypertension. Hypertens Dallas Tex 48:1116\u20131123. https:\/\/doi.org\/10.1161\/01.HYP.0000248430.26229.0f","journal-title":"Hypertens Dallas Tex"},{"key":"3925_CR31","doi-asserted-by":"publisher","first-page":"H136","DOI":"10.1152\/ajpheart.01417.2006","volume":"295","author":"M Iemitsu","year":"2008","unstructured":"Iemitsu M, Shimojo N, Maeda S et al (2008) The benefit of medium-chain triglyceride therapy on the cardiac function of SHRs is associated with a reversal of metabolic and signaling alterations. Am J Physiol Heart Circ Physiol 295:H136\u2013144. https:\/\/doi.org\/10.1152\/ajpheart.01417.2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"3925_CR32","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.cardfail.2015.07.009","volume":"21","author":"TD Nguyen","year":"2015","unstructured":"Nguyen TD, Shingu Y, Amorim PA et al (2015) Triheptanoin alleviates ventricular hypertrophy and improves myocardial glucose oxidation in rats with pressure overload. J Card Fail 21:906\u2013915. https:\/\/doi.org\/10.1016\/j.cardfail.2015.07.009","journal-title":"J Card Fail"},{"key":"3925_CR33","doi-asserted-by":"publisher","first-page":"23661","DOI":"10.1074\/jbc.M100942200","volume":"276","author":"T Hajri","year":"2001","unstructured":"Hajri T, Ibrahimi A, Coburn CT et al (2001) Defective fatty acid uptake in the spontaneously hypertensive rat is a primary determinant of altered glucose metabolism, hyperinsulinemia, and myocardial hypertrophy. J Biol Chem 276:23661\u201323666. https:\/\/doi.org\/10.1074\/jbc.M100942200","journal-title":"J Biol Chem"},{"key":"3925_CR34","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/0014-4827(76)90447-x","volume":"98","author":"BW Kimes","year":"1976","unstructured":"Kimes BW, Brandt BL (1976) Properties of a clonal muscle cell line from rat heart. Exp Cell Res 98:367\u2013381. https:\/\/doi.org\/10.1016\/0014-4827(76)90447-x","journal-title":"Exp Cell Res"},{"key":"3925_CR35","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s11626-010-9368-1","volume":"47","author":"SJ Watkins","year":"2011","unstructured":"Watkins SJ, Borthwick GM, Arthur HM (2011) The H9C2 cell line and primary neonatal cardiomyocyte cells show similar hypertrophic responses in vitro. In Vitro Cell Dev Biol Anim 47:125\u2013131. https:\/\/doi.org\/10.1007\/s11626-010-9368-1","journal-title":"In Vitro Cell Dev Biol Anim"},{"key":"3925_CR36","doi-asserted-by":"publisher","first-page":"H1822","DOI":"10.1152\/ajpheart.00396.2008","volume":"296","author":"R Saeedi","year":"2009","unstructured":"Saeedi R, Saran VV, Wu SSY et al (2009) AMP-activated protein kinase influences metabolic remodeling in H9c2 cells hypertrophied by arginine vasopressin. Am J Physiol Heart Circ Physiol 296:H1822\u20131832. https:\/\/doi.org\/10.1152\/ajpheart.00396.2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"3925_CR37","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/s1357-2725(00)00037-6","volume":"32","author":"MA Brostrom","year":"2000","unstructured":"Brostrom MA, Reilly BA, Wilson FJ, Brostrom CO (2000) Vasopressin-induced hypertrophy in H9c2 heart-derived myocytes. Int J Biochem Cell Biol 32:993\u20131006. https:\/\/doi.org\/10.1016\/s1357-2725(00)00037-6","journal-title":"Int J Biochem Cell Biol"},{"key":"3925_CR38","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1002\/ehf2.12319","volume":"5","author":"JA Chirinos","year":"2018","unstructured":"Chirinos JA, Sardana M, Oldland G et al (2018) Association of arginine vasopressin with low atrial natriuretic peptide levels, left ventricular remodelling, and outcomes in adults with and without heart failure. ESC Heart Fail 5:911\u2013919. https:\/\/doi.org\/10.1002\/ehf2.12319","journal-title":"ESC Heart Fail"},{"key":"3925_CR39","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1161\/01.res.84.3.365","volume":"84","author":"H Hupf","year":"1999","unstructured":"Hupf H, Grimm D, Riegger GA, Schunkert H (1999) Evidence for a vasopressin system in the rat heart. Circ Res 84:365\u2013370. https:\/\/doi.org\/10.1161\/01.res.84.3.365","journal-title":"Circ Res"},{"key":"3925_CR40","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ejphar.2006.12.010","volume":"559","author":"M Hiroyama","year":"2007","unstructured":"Hiroyama M, Wang S, Aoyagi T et al (2007) Vasopressin promotes cardiomyocyte hypertrophy via the vasopressin V1A receptor in neonatal mice. Eur J Pharmacol 559:89\u201397. https:\/\/doi.org\/10.1016\/j.ejphar.2006.12.010","journal-title":"Eur J Pharmacol"},{"key":"3925_CR41","doi-asserted-by":"publisher","first-page":"H552","DOI":"10.1152\/ajpheart.00626.2016","volume":"312","author":"MM Sung","year":"2017","unstructured":"Sung MM, Byrne NJ, Kim TT et al (2017) Cardiomyocyte-specific ablation of CD36 accelerates the progression from compensated cardiac hypertrophy to heart failure. Am J Physiol Heart Circ Physiol 312:H552\u2013H560. https:\/\/doi.org\/10.1152\/ajpheart.00626.2016","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"3925_CR42","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1002\/cbf.1449","volume":"26","author":"IK Adiga","year":"2008","unstructured":"Adiga IK, Nair RR (2008) Multiple signaling pathways coordinately mediate reactive oxygen species dependent cardiomyocyte hypertrophy. Cell Biochem Funct 26:346\u2013351. https:\/\/doi.org\/10.1002\/cbf.1449","journal-title":"Cell Biochem Funct"},{"key":"3925_CR43","first-page":"147","volume-title":"Progress in brain research","author":"M Thibonnier","year":"1999","unstructured":"Thibonnier M, Berti-Mattera LN, Dulin N et al (1999) Signal transduction pathways of the human V1-vascular, V2-renal, V3-pituitary vasopressin and oxytocin receptors. In: Urban IJA, Burbach JPH, De Wed D (eds) Progress in brain research. Elsevier, Amsterdam, pp 147\u2013161"},{"key":"3925_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2015.00149","author":"M Mutlak","year":"2015","unstructured":"Mutlak M, Kehat I (2015) Extracellular signal-regulated kinases 1\/2 as regulators of cardiac hypertrophy. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2015.00149","journal-title":"Front Pharmacol"},{"key":"3925_CR45","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1172\/JCI9056","volume":"105","author":"PM Barger","year":"2000","unstructured":"Barger PM, Brandt JM, Leone TC et al (2000) Deactivation of peroxisome proliferator\u2013activated receptor-\u03b1 during cardiac hypertrophic growth. J Clin Invest 105:1723\u20131730","journal-title":"J Clin Invest"},{"key":"3925_CR46","doi-asserted-by":"publisher","first-page":"5423","DOI":"10.1074\/jbc.273.10.5423","volume":"273","author":"Y Wang","year":"1998","unstructured":"Wang Y, Su B, Sah VP et al (1998) Cardiac hypertrophy induced by mitogen-activated protein kinase kinase 7, a specific activator for c-Jun NH2-terminal kinase in ventricular muscle cells. J Biol Chem 273:5423\u20135426. https:\/\/doi.org\/10.1074\/jbc.273.10.5423","journal-title":"J Biol Chem"},{"key":"3925_CR47","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1083\/jcb.139.1.115","volume":"139","author":"D Zechner","year":"1997","unstructured":"Zechner D, Thuerauf DJ, Hanford DS et al (1997) A role for the p38 mitogen-activated protein kinase pathway in myocardial cell growth, sarcomeric organization, and cardiac-specific gene expression. J Cell Biol 139:115\u2013127","journal-title":"J Cell Biol"},{"key":"3925_CR48","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1161\/01.RES.0000109415.17511.18","volume":"94","author":"BJ Wilkins","year":"2004","unstructured":"Wilkins BJ, Yan-Shan D, Bueno OF et al (2004) Calcineurin\/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy. Circ Res 94:110\u2013118. https:\/\/doi.org\/10.1161\/01.RES.0000109415.17511.18","journal-title":"Circ Res"},{"key":"3925_CR49","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1093\/jn\/127.6.1061","volume":"127","author":"J Odle","year":"1997","unstructured":"Odle J (1997) New insights into the utilization of medium-chain triglycerides by the neonate: observations from a piglet model. J Nutr 127:1061\u20131067","journal-title":"J Nutr"},{"key":"3925_CR50","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1093\/ajcn\/70.6.1001","volume":"70","author":"FB Hu","year":"1999","unstructured":"Hu FB, Stampfer MJ, Manson JE et al (1999) Dietary saturated fats and their food sources in relation to the risk of coronary heart disease in women. Am J Clin Nutr 70:1001\u20131008","journal-title":"Am J Clin Nutr"},{"key":"3925_CR51","doi-asserted-by":"publisher","first-page":"H1425","DOI":"10.1152\/ajpheart.00722.2004","volume":"288","author":"F Labarthe","year":"2004","unstructured":"Labarthe F (2004) Fatty acid oxidation and its impact on response of spontaneously hypertensive rat hearts to an adrenergic stress: benefits of a medium-chain fatty acid. AJP Heart Circ Physiol 288:H1425\u2013H1436. https:\/\/doi.org\/10.1152\/ajpheart.00722.2004","journal-title":"AJP Heart Circ Physiol"},{"key":"3925_CR52","doi-asserted-by":"publisher","first-page":"H140","DOI":"10.1152\/ajpheart.00424.2006","volume":"292","author":"MF Allard","year":"2007","unstructured":"Allard MF, Parsons HL, Saeedi R et al (2007) AMPK and metabolic adaptation by the heart to pressure overload. Am J Physiol Heart Circ Physiol 292:H140\u2013148. https:\/\/doi.org\/10.1152\/ajpheart.00424.2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"3925_CR53","first-page":"H1068","volume":"262","author":"Z el Alaoui-Talibi","year":"1992","unstructured":"el Alaoui-Talibi Z, Landormy S, Loireau A, Moravec J (1992) Fatty acid oxidation and mechanical performance of volume-overloaded rat hearts. Am J Physiol 262:H1068\u2013H1074","journal-title":"Am J Physiol"},{"key":"3925_CR54","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ymgme.2011.09.030","volume":"105","author":"AM Behrend","year":"2012","unstructured":"Behrend AM, Harding CO, Shoemaker JD et al (2012) Substrate oxidation and cardiac performance during exercise in disorders of long chain fatty acid oxidation. Mol Genet Metab 105:110\u2013115. https:\/\/doi.org\/10.1016\/j.ymgme.2011.09.030","journal-title":"Mol Genet Metab"},{"key":"3925_CR55","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1073\/pnas.0336724100","volume":"100","author":"BN Finck","year":"2003","unstructured":"Finck BN, Han X, Courtois M et al (2003) A critical role for PPARalpha-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: modulation by dietary fat content. Proc Natl Acad Sci USA 100:1226\u20131231. https:\/\/doi.org\/10.1073\/pnas.0336724100","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-020-03925-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-020-03925-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-020-03925-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T21:13:50Z","timestamp":1632950030000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-020-03925-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,30]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["3925"],"URL":"https:\/\/doi.org\/10.1007\/s11010-020-03925-1","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,30]]},"assertion":[{"value":"1 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Saifudeen Ismael was a recipient of Senior Research Fellowship from the Indian Council of Medical Research, India. No conflict of interest to be declared.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}